期刊文献+

HIV-1潜伏储存库及其控制策略 被引量:3

Treatment strategy of anti-HIV-1 latency
原文传递
导出
摘要 高效抗逆转录病毒治疗(HAART)是人类在治疗人类免疫缺陷病毒(HIV)感染/艾滋病(AIDS)方面取得的一个重要成就。HAART不仅可以有效控制HIV复制,将血浆病毒载量降至现有常规检测方法测不出的水平,而且能重建艾滋病患者的免疫功能[1],延长患者生命,降低死亡率。HAART体系建立时人们希望能够完全清除患者体内的HIV,达到治愈AIDS的目的 ,
作者 宋静静 吴昊
出处 《中国病毒病杂志》 CAS 2011年第4期251-253,共3页 Chinese Journal of Viral Diseases
基金 国家"十一五"艾滋病和病毒性肝炎等重大传染病防治科技重大专项(2008ZX10001-006 2008ZX10001-001)
关键词 HIV-1 潜伏库 治疗 HIV-1 Latent reservoir Therapy
  • 相关文献

参考文献23

二级参考文献111

  • 1Ho D D,Neumann A U,Perelson A S,et al.Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection[J].Nature,1995,373:123-126.
  • 2Perelson A S,Essunger P,Can Y,et al.Decay characteristics of HIV-1-infected compartments during combination therapy[J].Nature,1997,387:188-191.
  • 3Natarajan V,Bosche M,Metcalf J A,et al.HIV-1 replication in patients with undetectable plasma virus receiving HAART.Highly active anfiretruviral therapy[J].Lancet,1999,353:119-120.
  • 4Pope M,Haase A T.Transmission,acute HIV-1 infection and the quest for strategies to prevent infection[J].Nat Med,2003,9:847-852.
  • 5Agosto L M,Yu J J,Dai J,et al.HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration[J].Virology,2007,368:60-72.
  • 6Blazkova J,Trejbalova K,Gondois-Rey F,et al.CpG methylation controls reactivation of HIV from latency[J].PLoS Pathog,2009,5:e1000554.
  • 7Jeeninga R E,Westerhout E M,van Gerven M L,et al.HIV-1 latency in actively dividing human T cell lines[J].Retrovirology,2008,5:37.
  • 8Ramratnam B,Mittler J E,Zhang L,et al.The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy[J].Nat Med,2000,6:82-85.
  • 9Lefebvre J C,Durant J,Koechlin A,et al.HIV-1 and persistent clinical latency,TAR element analysis and improved method for in vitro viral reactivation[J].J Clin Virol,2007,38:348-352.
  • 10Fraser C,Fergusen N M,Ghani A C,et al.Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs[J].AIDS,2000,14:659-669.

共引文献45

同被引文献32

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部